Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,476 | -8,953 | -4,932 | -15,274 | -10,137 |
| Depreciation Amortization | 3 | 2 | 1 | 12 | 9 |
| Accounts payable and accrued liabilities | -483 | -680 | -877 | 2,304 | N/A |
| Other Working Capital | 1,094 | 144 | -184 | 3,164 | 960 |
| Other Operating Activity | 1,259 | 1,259 | 1,167 | -764 | 916 |
| Operating Cash Flow | $-11,604 | $-8,227 | $-4,825 | $-10,558 | $-8,253 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | N/A | N/A | -4 | -4 |
| Investing Cash Flow | $-2 | $N/A | $N/A | $-4 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,828 | 2,695 | 1 | 16,041 | 10,628 |
| Other Financing Activity | -368 | -244 | -121 | -428 | -349 |
| Financing Cash Flow | $2,460 | $2,451 | $-120 | $15,613 | $10,280 |
| Beginning Cash Position | 10,055 | 10,055 | 10,055 | 5,005 | 5,005 |
| End Cash Position | 910 | 4,279 | 5,111 | 10,055 | 7,028 |
| Net Cash Flow | $-9,146 | $-5,776 | $-4,945 | $5,051 | $2,023 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,604 | -8,227 | -4,825 | -10,558 | -8,253 |
| Capital Expenditure | -2 | N/A | N/A | -4 | -4 |
| Free Cash Flow | -11,605 | -8,227 | -4,825 | -10,562 | -8,257 |